Compound Evidence File
#EC-2026-0723
HGH Fragment 176-191
Filed under Peptides. The bureau holds 135 laboratory returns for this compound from 53 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
53 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 3 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 16 May 2026 | 10 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 28 Apr 2026 | 8 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 10.0 | 10.0 | 9 Mar 2026 | 16 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Dec 2025 | 4 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 20 Nov 2025 | 7 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Jan 2026 | 3 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Nov 2025 | 15 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Dec 2025 | 15 Apr 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Dec 2025 | 12 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 10.0 | 10.0 | 18 Jan 2026 | 18 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Apr 2026 | 16 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Dec 2025 | 7 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 9.9 | 3 May 2026 | 16 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Mar 2026 | 10 Mar 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 9 Apr 2026 | 12 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Nov 2025 | 16 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Jun 2026 | 28 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 25 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Jul 2026 | 14 Jul 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 9.6 | 9.3 | 9.9 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 9.4 | 8.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 9.4 | 9.2 | 9.7 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 9.0 | 8.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.2 | 7.1 | 9.3 | 23 May 2026 | 23 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 8.1 | 8.1 | 8.1 | 9 Jun 2025 | 9 Jun 2025 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 | 3 Jul 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 | 3 Jul 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 | 3 Jun 2025 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 7.7 | 7.7 | 7.7 | 11 Jun 2025 | 11 Jun 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 8 | 7.5 | 6.2 | 9.5 | 28 Mar 2025 | 19 Jan 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 6 | 7.4 | 5.8 | 8.8 | 20 Jun 2025 | 21 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 2 | 7.4 | 7.0 | 7.8 | 20 Jun 2025 | 19 Jan 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 3 | 7.3 | 6.1 | 9.2 | 11 Jun 2025 | 23 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.3 | 7.3 | 7.3 | 14 Jan 2025 | 14 Jan 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 | 3 Jul 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 7.2 | 7.2 | 7.2 | 9 Jun 2025 | 9 Jun 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 6.8 | 6.8 | 6.8 | 25 Apr 2025 | 25 Apr 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 6.7 | 4.5 | 9.6 | 9 Jun 2025 | 19 Jan 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 6.6 | 6.4 | 6.7 | 7 May 2025 | 24 May 2026 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 2 | 6.6 | 5.2 | 7.9 | 21 May 2025 | 23 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 | 2 Apr 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 | 21 May 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 | 8 Jul 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 | 17 Dec 2024 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 5.6 | 5.6 | 5.6 | 24 Apr 2025 | 24 Apr 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 5.5 | 5.5 | 5.5 | 21 May 2025 | 21 May 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | X | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 | 7 May 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 5.3 | 5.3 | 5.3 | 16 Mar 2025 | 16 Mar 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for HGH Fragment 176-191 alone.